High-throughput screening assay for macrocyclic peptides developed
A high-throughput screening assay for macrocyclic peptides with affinity to ubiquitin has been created by researchers.
List view / Grid view
A high-throughput screening assay for macrocyclic peptides with affinity to ubiquitin has been created by researchers.
Researchers have developed a computer modelling programme that can produce genetic circuits for cellular engineering.
Using liquid chromatography/mass spectrometry, researchers have revealed no major differences in glycan structures in two prion strains.
Research has shown that MAPK4 activates two molecules in cellular signalling pathways involved in prostate cancer growth.
A version of the FOXO3 gene can protect brain stem cells from stress during ageing, according to a new study.
The UK Government will give £18.5 million in funding to four studies researching the causes and potential treatments of long COVID.
Researchers have shown that adding a polymer to glutamate-oxaloacetate transaminase means the molecule can treat stroke for up to six days in rats.
For the first time, scientists have grown bile duct organoids that could repair damaged ducts and livers as a new cell therapy.
A report has been backed by eight industry leaders who say that updating R&D tax credit systems in the UK would release £4 billon of growth every year.
High IFN signalling in pancreatic tumours are sensitive to NAMPT inhibitors which block a pathway in NAD synthesis, presenting a drug target.
A study has shown the D614G mutation in the Spike protein of SARS-CoV-2 makes the coronavirus more transmissible than the original virus from China.
A proton therapy that targets cancer cells which are resistant to treatment has shown success, sparing surrounding healthy cells.
A peptide administered to ferrets protected them from SARS-CoV-2 viral transmission when housed with infected ferrets.
A novel nanotherapy can decrease intestinal inflammation and shrink lesions in rodent models of Crohn's disease, a study has shown.
The drug combination of difluoromethylornithine and AMXT 1501 has shown success against Diffuse Intrinsic Pontine Glioma in animal models.